Trial Information
Endothelial Function, Arterial Stiffness and Components of Metabolic Syndrome in Acute Lymphoblastic Leukemia (ALL) Survivors
Inclusion Criteria:
Survivor:
Inclusion
1. Ages 8-28 (8 is chosen as lower age limit because developmental understanding will
allow survivor to follow instructions for procedures, 28 is chosen as upper limit to
include age ranges seen for treatment in the pediatric program)
2. Off therapy for at least 6 months and not more than 10 years (6 months
Inclusion
1. Biological sibling
2. Ages 8-28 (when more than one sibling is available the one closest in age will be
chosen.))
Exclusion Criteria:
1. Uncontrolled medical conditions that could interfere with participation or
interpretation of results
2. History of relapsed ALL or history of bone marrow transplantation
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Cross-Sectional
Outcome Measure:
measure of endothelial
Outcome Time Frame:
at enrollment
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
J1064
NCT ID:
NCT01439217
Start Date:
June 2011
Completion Date:
February 2013
Related Keywords:
- Acute Lymphoblastic Leukemia
- Acute lymphoblastic leukemia
- Survivor
- Sibling control
- Leukemia
- Leukemia, Lymphoid
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
Name | Location |
Sidney Kimmel Comprehensive Cancer Center |
Lutherville, Maryland |
Johns Hopkins Hospital |
Baltimore, Maryland 21287 |